Literature DB >> 234806

Angiotensin I converting enzyme.

E G Erdös.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234806     DOI: 10.1161/01.res.36.2.247

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  44 in total

Review 1.  Regulatory functions of the coronary endothelium.

Authors:  V W van Hinsbergh
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

2.  Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom.

Authors:  Wafa Medjadba; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 3.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

Review 5.  Antihypertensive drugs and glucose metabolism.

Authors:  Christos V Rizos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2014-07-26

Review 6.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

Review 7.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

Review 8.  Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.

Authors:  B Waeber; L Juillerat-Jeanneret; J F Aubert; M Schapira; J Nussberger; H R Brunner
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

9.  A lack of effect of captopril on platelet aggregation in patients with congestive heart failure.

Authors:  I F Gow; A D Flapan; M Morris; E Davies; B C Williams; P L Padfield; T R Shaw; C R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.